I've had some bad ones but this takes the case,

First 3 Last

Share
Profile

Follow
nwad

99 Posts.

30

07/11/22

17:28

Post #: 64633169
Share
Originally posted by Joelsmith2452: ↑

I suggest everyone on here send a similar email to mine below. It is the only way this company will know that we the shareholders are NOT HAPPY and that they need to pick up their act if they are going to continue to cash their rediculous paychecks and "earn" their bonuses....

Hello,
As an investor in this company I would like to know if the developments listed below are still in the works or have they ceased?
It would be nice to have SPL make an announcement to the market to clear up the uncertainty around the many market sensitive announcements made that seem to have just faded into the background with no update as to whether they are progressing or if they have ceased.
Zika Virus opportunity – Fail
Viral Conjunctivitis development – Please provide an update on whether SPL is still pursuing this opportunity
Global condom revenue –Quarterly Reports only list revenue as receipts from customers – Can you please split this out and list where the revenues are coming from? i.e. Condoms, Vivagel, Viraleze etc….
VivaGel global revenue – Quarterly Reports only list revenue as receipts from customers – Can you please split this out and list where the revenues are coming from? i.e. Condoms, Vivagel, Viraleze etc….
FDA approval for VivaGel – Please provide full details of why the FDA has rejected the Vivagel application. This has never been provided to shareholders
US Govt BARDA grant for Viraleze – Please provide full details of why the FDA has rejected the Vivagel application. This has never been provided to shareholders
DEP Remdesevir opportunity with Gilead – This was promoted as price sensitive. No update has been given to the market as to progress or if this opportunity is still alive
Viraleze for Olympic teams – This was promoted as price sensitive, yet there was no explanation to the market when this did not go ahead
Indian partnership for Viraleze- This was promoted as price sensitive, yet there was no explanation to the market when this did not go ahead
TGA for Viraleze – Please provide a status update on where this approval stands
Further Viraleze partners in European football – The partnership with Harlequins rugby was promoted, why have SPL not pursued more sporting teams to partner with?
Saudi Viraleze launch – This was promoted as price sensitive, yet there was no explanation to the market when this did not go ahead
DEP Docetaxel Ph2 completion by 2018 – We have been continuously been told that this trial is close to completion, however here we are approaching 2023 and still nothing……
Timelines for multiple internal DEP trials – Please provide expected timelines for completion of these trials.
Condom registration in China – Another price sensitive announcement that has gone nowhere with ZERO explanation.

Expand

I've had some bad ones but this takes the case,
SPL Price at posting: 49.0¢ Sentiment: None Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

PAR

FDA hands Paradigm Biopharma guidance to re-jig phase 3 osteo trial – or is it a delay?

ASX Market Open: Australian bourse to fall as subdued Wall Street awaits rate cut decision | September 18, 2024

HVN

Harvey Norman clocks subdued gains as Echo Law's junk warranty class action kicks off

CXU

Cauldron discovers shallow uranium up to 2km at WA's Yanrey

88E

HotCopper users smell capital raising as 88 Energy says "significant update" at Phoenix

There are more pages in this discussion • 2 more messages in this thread...

First 3 Last

Add SPL (ASX) to my watchlist

(20min delay)
Last 10.0¢		Change 0.003(3.09%)		Mkt cap ! $41.73M

Open	High	Low	Value	Volume
9.9¢	10.5¢	9.9¢	$12.72K	127.5K

Buyers (Bids)

No.	Vol.	Price($)
2	50204	9.8¢

Sellers (Offers)

Price($)	Vol.	No.
10.0¢	64981	2

View Market Depth

No.	Vol.	Price($)
2	50204	0.098
4	865495	0.097
1	50000	0.096
3	176316	0.095
2	110000	0.094

Price($)	Vol.	No.
0.100	64981	2
0.105	90878	3
0.110	210058	7
0.115	122327	4
0.120	59907	7

Last trade - 10.43am 18/09/2024 (20 minute delay)

SPL (ASX) Chart

I've had some bad ones but this takes the case,

FDA hands Paradigm Biopharma guidance to re-jig phase 3 osteo trial – or is it a delay?

ASX Market Open: Australian bourse to fall as subdued Wall Street awaits rate cut decision | September 18, 2024

Harvey Norman clocks subdued gains as Echo Law's junk warranty class action kicks off

Cauldron discovers shallow uranium up to 2km at WA's Yanrey

HotCopper users smell capital raising as 88 Energy says "significant update" at Phoenix

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

I've had some bad ones but this takes the case,

Top Stories

FDA hands Paradigm Biopharma guidance to re-jig phase 3 osteo trial – or is it a delay?

ASX Market Open: Australian bourse to fall as subdued Wall Street awaits rate cut decision | September 18, 2024

Harvey Norman clocks subdued gains as Echo Law's junk warranty class action kicks off

Cauldron discovers shallow uranium up to 2km at WA's Yanrey

HotCopper users smell capital raising as 88 Energy says "significant update" at Phoenix

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News